CBO examines drug purchases made through the 340B program in 2021, growth in such purchases from 2010 to 2021, and factors that contributed to that growth. CBO also assesses how the 340B program affects the federal budget.
CBO Blog
CBO commemorated its 50th anniversary with an event in the Capitol Visitor Center Auditorium—a celebration of the agency's enduring legacy and its nonpartisan mission first defined by CBO's founding director, Alice Rivlin.
As tariffs changed frequently throughout 2025, CBO has regularly updated the Congress about projected tariff revenues; this blog post is the latest in that series.
CBO provides an overview of the main components of greenhouse gas emissions from agriculture, recent trends in those emissions, and projections of future emissions.
CBO announces the release schedule for several publications next month that provide updated information on the federal budget, demographic trends, and the short-term economic outlook.
As required by law, CBO reports on whether appropriations enacted for the current fiscal year have exceeded the statutory caps on discretionary funding. In CBO's estimation, they have not, and a sequestration will not be required for 2025.
The federal budget deficit totaled $1.6 trillion in the first 10 months of fiscal year 2025, CBO estimates. That amount is $109 billion more than the deficit recorded during the same period last fiscal year.
CBO's Director, Phillip Swagel, highlights his recent speaking engagements and the topics he discussed.
CBO addresses seven key issues that might arise as it estimates the budgetary effects of potential legislation or administrative actions that could result in releasing Fannie Mae and Freddie Mac from government control.
CBO assesses its two-year and five-year economic forecasts from as early as 1976 and compares them with those of the Administration, the Survey of Professional Forecasters, and the Blue Chip consensus.